Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection Fraction

Background: Data on the impact of sacubitril/valsartan (SV) therapy on phasic left atrial (LA) and left ventricular (LV) strain in heart failure with reduced ejection fraction (HFrEF) are limited. The aim of this study was to evaluate changes in two-dimensional speckle tracking (2D-STE) parameters w...

Full description

Bibliographic Details
Main Authors: Pedro Garcia Brás, António Valentim Gonçalves, Luísa Moura Branco, Rita Ilhão Moreira, Tiago Pereira-da-Silva, Ana Galrinho, Ana Teresa Timóteo, Pedro Rio, Ana Leal, Fernanda Gameiro, Rui M. Soares, Rui Cruz Ferreira
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/4/995
_version_ 1797604679792721920
author Pedro Garcia Brás
António Valentim Gonçalves
Luísa Moura Branco
Rita Ilhão Moreira
Tiago Pereira-da-Silva
Ana Galrinho
Ana Teresa Timóteo
Pedro Rio
Ana Leal
Fernanda Gameiro
Rui M. Soares
Rui Cruz Ferreira
author_facet Pedro Garcia Brás
António Valentim Gonçalves
Luísa Moura Branco
Rita Ilhão Moreira
Tiago Pereira-da-Silva
Ana Galrinho
Ana Teresa Timóteo
Pedro Rio
Ana Leal
Fernanda Gameiro
Rui M. Soares
Rui Cruz Ferreira
author_sort Pedro Garcia Brás
collection DOAJ
description Background: Data on the impact of sacubitril/valsartan (SV) therapy on phasic left atrial (LA) and left ventricular (LV) strain in heart failure with reduced ejection fraction (HFrEF) are limited. The aim of this study was to evaluate changes in two-dimensional speckle tracking (2D-STE) parameters with SV therapy in HFrEF patients. Methods: Prospective evaluation of HFrEF patients receiving optimized medical therapy. Two-dimensional speckle tracking (2D-STE) parameters were assessed at baseline and after 6 months of SV therapy. LA strain and strain rate (SR) in reservoir, conduit, and contraction phases were compared with LV longitudinal, radial, and circumferential strain and SR and stratified according to heart rhythm and HFrEF etiology. Results: A total of 35 patients completed the 6-month follow-up, with a mean age of 59 ± 11 years, 40% in atrial fibrillation, 43% with ischemic etiology, and LVEF of 29 ± 6%. There were significant improvements in LA reservoir, conduit, and contractile strain and SR following SV therapy, particularly among patients in sinus rhythm. There were significant improvements in longitudinal, radial, and circumferential LV function indices. Conclusion: SV therapy in HFrEF was associated with improved longitudinal, radial, and circumferential function, particularly among patients in sinus rhythm. These findings can provide insights into the mechanisms underlying the improvement of cardiac function and help assess subclinical responses to the treatment.
first_indexed 2024-03-11T04:50:10Z
format Article
id doaj.art-91b9b07731cf41f1a845d736bc6bbb0a
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-11T04:50:10Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-91b9b07731cf41f1a845d736bc6bbb0a2023-11-17T20:06:37ZengMDPI AGLife2075-17292023-04-0113499510.3390/life13040995Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection FractionPedro Garcia Brás0António Valentim Gonçalves1Luísa Moura Branco2Rita Ilhão Moreira3Tiago Pereira-da-Silva4Ana Galrinho5Ana Teresa Timóteo6Pedro Rio7Ana Leal8Fernanda Gameiro9Rui M. Soares10Rui Cruz Ferreira11Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalHospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, 1169-024 Lisbon, PortugalBackground: Data on the impact of sacubitril/valsartan (SV) therapy on phasic left atrial (LA) and left ventricular (LV) strain in heart failure with reduced ejection fraction (HFrEF) are limited. The aim of this study was to evaluate changes in two-dimensional speckle tracking (2D-STE) parameters with SV therapy in HFrEF patients. Methods: Prospective evaluation of HFrEF patients receiving optimized medical therapy. Two-dimensional speckle tracking (2D-STE) parameters were assessed at baseline and after 6 months of SV therapy. LA strain and strain rate (SR) in reservoir, conduit, and contraction phases were compared with LV longitudinal, radial, and circumferential strain and SR and stratified according to heart rhythm and HFrEF etiology. Results: A total of 35 patients completed the 6-month follow-up, with a mean age of 59 ± 11 years, 40% in atrial fibrillation, 43% with ischemic etiology, and LVEF of 29 ± 6%. There were significant improvements in LA reservoir, conduit, and contractile strain and SR following SV therapy, particularly among patients in sinus rhythm. There were significant improvements in longitudinal, radial, and circumferential LV function indices. Conclusion: SV therapy in HFrEF was associated with improved longitudinal, radial, and circumferential function, particularly among patients in sinus rhythm. These findings can provide insights into the mechanisms underlying the improvement of cardiac function and help assess subclinical responses to the treatment.https://www.mdpi.com/2075-1729/13/4/995left atrial strainlongitudinal strainradial straincircumferential strainspeckle tracking echocardiographysacubitril/valsartan
spellingShingle Pedro Garcia Brás
António Valentim Gonçalves
Luísa Moura Branco
Rita Ilhão Moreira
Tiago Pereira-da-Silva
Ana Galrinho
Ana Teresa Timóteo
Pedro Rio
Ana Leal
Fernanda Gameiro
Rui M. Soares
Rui Cruz Ferreira
Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection Fraction
Life
left atrial strain
longitudinal strain
radial strain
circumferential strain
speckle tracking echocardiography
sacubitril/valsartan
title Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection Fraction
title_full Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection Fraction
title_fullStr Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection Fraction
title_full_unstemmed Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection Fraction
title_short Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection Fraction
title_sort sacubitril valsartan improves left atrial and ventricular strain and strain rate in patients with heart failure with reduced ejection fraction
topic left atrial strain
longitudinal strain
radial strain
circumferential strain
speckle tracking echocardiography
sacubitril/valsartan
url https://www.mdpi.com/2075-1729/13/4/995
work_keys_str_mv AT pedrogarciabras sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT antoniovalentimgoncalves sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT luisamourabranco sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT ritailhaomoreira sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT tiagopereiradasilva sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT anagalrinho sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT anateresatimoteo sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT pedrorio sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT analeal sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT fernandagameiro sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT ruimsoares sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction
AT ruicruzferreira sacubitrilvalsartanimprovesleftatrialandventricularstrainandstrainrateinpatientswithheartfailurewithreducedejectionfraction